Q1 FY27 results analysis · July 24, 2026

Acutaas Chemicals Ltd Q1 FY27 Results Analysis: PAT Surges 68%, Margin Compresses 811 bps QoQ

+67.7%PAT year on year, Rs. 74.26 Cr
Cofacto ResearchPublished July 24, 20262 min readNeutral read
Quick summary

Acutaas Chemicals Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 329.67 Cr (+59.08% YoY) and PAT growth of +67.67% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 24, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 329.67 Cr (+59.08% YoY)
PAT (Q1)Rs. 74.26 Cr (+67.67% YoY)
EBITDA margin34.30% (+974 bps YoY)
EPS (Q1)Rs. 9.07 (+67.65% YoY)
Market capRs. 26,710.60 Cr
CMPRs. 3,259.50

Quarter Snapshot

ACUTAAS delivered strong YoY revenue growth of 59% and PAT growth of 68%, with EBITDA margin expanding 974 bps YoY. However, the quarter saw a sharp sequential decline of 24% in revenue and an 811 bps QoQ margin compression, driven by higher raw material costs and employee expenses. No management guidance or forward-looking commentary was provided, limiting visibility on future trajectory.

Key Investment Insights

Key Positives

  • Consolidated revenue grew 59.08% YoY to Rs.329.67 Cr from Rs.207.24 Cr in Q1FY26
  • PAT (owners) grew 67.67% YoY to Rs.74.26 Cr from Rs.44.29 Cr
  • EBITDA margin expanded 974 bps YoY to 34.30% from 24.56%
  • EBITDA grew 122.10% YoY to Rs.113.07 Cr from Rs.50.91 Cr
  • Effective tax rate remains moderate at 27.83%

Risk Factors

  • Revenue declined 23.82% QoQ from Rs.432.75 Cr in Q4FY26, a sharp sequential drop
  • EBITDA margin compressed 811 bps QoQ from 42.41% to 34.30%
  • Cost of materials as % of revenue rose 8pp QoQ to 50.28%, pressuring gross margins
  • Employee benefits expense grew 18.86% QoQ, indicating rising fixed cost base from capex expansion

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.